全文获取类型
收费全文 | 26249篇 |
免费 | 2114篇 |
国内免费 | 953篇 |
专业分类
耳鼻咽喉 | 114篇 |
儿科学 | 350篇 |
妇产科学 | 465篇 |
基础医学 | 2293篇 |
口腔科学 | 365篇 |
临床医学 | 1971篇 |
内科学 | 5791篇 |
皮肤病学 | 427篇 |
神经病学 | 1456篇 |
特种医学 | 317篇 |
外国民族医学 | 6篇 |
外科学 | 2129篇 |
综合类 | 2415篇 |
现状与发展 | 14篇 |
预防医学 | 437篇 |
眼科学 | 399篇 |
药学 | 5713篇 |
8篇 | |
中国医学 | 555篇 |
肿瘤学 | 4091篇 |
出版年
2024年 | 64篇 |
2023年 | 542篇 |
2022年 | 876篇 |
2021年 | 1227篇 |
2020年 | 1023篇 |
2019年 | 953篇 |
2018年 | 970篇 |
2017年 | 945篇 |
2016年 | 837篇 |
2015年 | 1003篇 |
2014年 | 1628篇 |
2013年 | 2519篇 |
2012年 | 1376篇 |
2011年 | 1657篇 |
2010年 | 1245篇 |
2009年 | 1340篇 |
2008年 | 1471篇 |
2007年 | 1371篇 |
2006年 | 1298篇 |
2005年 | 1144篇 |
2004年 | 940篇 |
2003年 | 788篇 |
2002年 | 599篇 |
2001年 | 494篇 |
2000年 | 373篇 |
1999年 | 334篇 |
1998年 | 284篇 |
1997年 | 264篇 |
1996年 | 228篇 |
1995年 | 206篇 |
1994年 | 161篇 |
1993年 | 135篇 |
1992年 | 103篇 |
1991年 | 114篇 |
1990年 | 118篇 |
1989年 | 93篇 |
1988年 | 80篇 |
1987年 | 45篇 |
1986年 | 53篇 |
1985年 | 80篇 |
1984年 | 70篇 |
1983年 | 43篇 |
1982年 | 48篇 |
1981年 | 45篇 |
1980年 | 33篇 |
1979年 | 21篇 |
1978年 | 23篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1974年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
In this review we consider the evidence that growth hormone (GH) acts in the embryo as a local growth, differentiation, and cell survival factor. Because both GH and its receptors are present in the early embryo before the functional differentiation of pituitary somatotrophs and before the establishment of a functioning circulatory system, the conditions are such that GH may be a member of the large battery of autocrine/paracrine growth factors that control embryonic development. It has been clearly established that GH is able to exert direct effects, independent of insulin-like growth factor-I (IGF-I), on the differentiation, proliferation, and survival of cells in a wide variety of tissues in the embryo, fetus, and adult. The signaling pathways behind these effects of GH are now beginning to be determined, establishing early extrapituitary GH as a bona fide developmental growth factor. 相似文献
82.
The present study investigates the effects of bis(7)-tacrine, a novel dimeric acetylcholinesterase inhibitor, on hydrogen peroxide(H2O2)-induced cell injury with comparison to the corresponding monomer, tacrine. Exposure of rat pheochromocytoma line PC12 cells to H2O2 induced significant cell damage. This reagent also caused redox desequilibrium as indicated by a decrease in activities of intracellular antioxidant enzymes such as glutathione peroxidase as well as catalase and an accumulation of malondialdehyde, a product of lipid peroxidation. Pretreatment of cells with bis(7)-tacrine or tacrine attenuated H2O2-induced cell toxicity, and bis(7)-tacrine demonstrated higher potency than tacrine in improving redox desequilibrium. These results suggest that bis(7)-tacrine and tacrine significantly protect against H2O2 insult, which might be beneficial for their potential usage in the prevention and treatment of Alzheimer's disease. 相似文献
83.
A controlled study of a specific MAO A reversible inhibitor (R011-1163) and amitriptyline in depressive illness 总被引:2,自引:0,他引:2
A double blind comparative study of amitriptyline and a new reversible MAO A inhibitor R011-1163 was conducted in 25 depressed inpatients over 4 weeks. Response to treatment was assessed with the Hamilton depression rating scale, the Carroll depression self rating scale and the Visual analogue scale. Both drugs produced significant changes in depressive symptomatology (P less than 0.01, MANOVA) and there were no statistically significant differences between drugs (P greater than 0.05 MANOVA). Side effects were of mild to moderate severity with dry mouth the most commonly reported side effect of amitriptyline and vague, generalised headache in patients, treated with R011-1163. 相似文献
84.
Skin deposits in hereditary cystatin C amyloidosis 总被引:3,自引:0,他引:3
Eiríkur Benedikz Hannes Blöndal Gunnar Gudmundsson 《Virchows Archiv : an international journal of pathology》1990,417(4):325-331
Summary Clinically normal skin from 47 individuals aged 9–70 years was investigated. Cystatin C amyloid deposits were found in various locations of the skin by light and/or electron microscopy, in all 12 patients with a clinical history of hereditary cystatin C amyloidosis (HCCA). Six asymptomatic individuals, who had the Alu 1 restriction fragment length polymorphism (RFLP) marker reported to cosegregate with the disease, also had cystatin C amyloid deposits in the skin. Three asymptomatic individuals (age 17–46) belonging to the HCCA families were without amyloid in the skin but had Alu 1 RFLP marker. Skin from 12 individuals who served as controls and skin from 14 close relatives of the patients was negative for amyloid. Punch biopsy of the skin is a simple procedure which is of value for the diagnosis of HCCA, even before the appearance of clinical symptoms. This method might also be of use in following progression of the disease. 相似文献
85.
The role of COX-2 in angiogenesis and rheumatoid arthritis 总被引:4,自引:0,他引:4
Woods JM Mogollon A Amin MA Martinez RJ Koch AE 《Experimental and molecular pathology》2003,74(3):282-290
Recent evidence suggests that cyclooxygenase (COX)-2 is a mediator of angiogenesis, and COX-2 activity is known to be upregulated in the rheumatoid arthritis (RA) synovium. We examined whether mediation of angiogenesis by COX-2 was occuring in cells of the RA synovium and in microvascular endothelial cells (ECs) that are similar to those found in the RA synovium. We demonstrate that rofecoxib, a selective COX-2 inhibitor, acts directly on human dermal microvascular ECs (HMVECs) to inhibit their chemotactic and tube forming ability. Likewise, pretreatment of HMVECs with rofecoxib significantly inhibited their ability to form tubes induced by conditioned media (CM) of activated RA synovial fibroblasts. When RA synovial fibroblasts were pretreated with rofecoxib for 16 h and then stimulated with interleukin (IL)-1beta, their CM induced significantly less HMVEC tube formation when compared with CM from vehicle-treated RA synovial fibroblasts. ELISAs performed on activated RA fibroblast CM for known proangiogenic factors demonstrated a significant reduction in bFGF, in addition to the expected decrease in PGE(2). Our studies suggest that COX-2-induced angiogenic activity is an active mechanism within diseased synovium and may provide an additional rationale for the use of COX-2 inhibitors in RA. 相似文献
86.
87.
Yang AH Chen JY Chen BF 《Virchows Archiv : an international journal of pathology》2004,445(3):305-314
While diffuse mesangial sclerosis is traditionally described as being the glomerulopathy of Denys–Drash syndrome (DDS), the podocyte proliferative lesions may be overlooked in these DDS cases. In the present study, an evolving process is extrapolated from a selected case of DDS that demonstrated glomerulopathy with conspicuous podocyte proliferation. The observation that podocytes express proliferation markers (Ki67, proliferating-cell nuclear antigen and topoisomerase II) in non-proliferative, mature-looking glomeruli suggests an initial pathogenic act to activate or to keep podocytes from quiescence. The subsequent proliferation of podocytes is in keeping with downregulation of WT1 and cyclin kinase inhibitors of p16 and p21. The emergence of cytokeratin-positive cells in glomeruli that show typical mesangial sclerosis implies elimination of podocytes and replacement with tubular and/or parietal epithelial cells. The final scene of evolving glomerulopathy displays apoptosis and expression of Fas-L and Bax in sclerotic mesangial lesions, which eventually end up with global sclerosis. This novel concept of DDS glomerulopathy implies complex molecular mechanisms involved in glomerular injury. 相似文献
88.
Inge Van de Walle Karen Silence Kevin Budding Liesbeth Van de Ven Kim Dijkxhoorn Elisabeth de Zeeuw Cafer Yildiz Sofie Gabriels Jean-Michel Percier Johanna Wildemann Jan Meeldijk Peter J. Simons Louis Boon Linda Cox Rob Holgate Rolf Urbanus Henny G. Otten Jeanette H.W. Leusen Peter Boross 《The Journal of allergy and clinical immunology》2021,147(4):1420-1429.e7
89.
S. Suzuki T. Iwabuchi T. Tanaka S. Kanayama M. Ottomo M. Hatanaka H. Aihara 《Acta neurochirurgica》1985,77(3-4):133-141
Summary The prevention of cerebral vasospasm with OKY-046, an imidazole derivative and a thromboxane synthetase inhibitor, was studied co-operatively at ten neurosurgical services. Intravenous administrations of 2, 5 or 10 /kg/minute of OKY-046 were given continuously from the earliest possible day to the 14th SAH-day to 82 pateints with ruptured cerebral aneurysm. Sixty-eight patients (83%) showed moderate to high high-density (SAH) in their initial CTs. Angiographic vasospasms were seen in 58 patients, representing 71% of all cases or 81% of the 72 cases for which angiograms were available; the vasospasms of 45 patients (55 or 63%) were moderate to severe. Symptomatic vasospasm occurred, however, only in 27 patients (33%); in 18 of those cases, moreover, the symptoms were mild or transient. The conditions of the patients at one month after the SAH were classified into 9 grades from 0 (normal) to 8 (deceased). Fifty-two patients (63%) were classified as 0 or 1, and 64 (78%) as better than 3 (possible daily life unaided). The administration of OKY-046 was proven to decrease TXB2 in the blood.This paper emphasizes the effectiveness of the drug for symptomatic vasospasm, and supports our previous contention that cerebral microthrombosis may play an important role in the pathogenesis of cerebral vasospasm. 相似文献
90.
R. Ortmann M. Schaub A. Felner J. Lauber P. Christen P. C. Waldmeier 《Psychopharmacology》1984,84(1):22-27
Stereotyped sniffing behavior together with forepaw padding — defined as the -phenylethylamine (PEA) syndrome — is induced by MAO-B inhibitors in rats injected with 30 mg/kg IP PEA. The comparison of the abilities of the MAO-B inhibitors to induce the syndrome and to inhibit MAO-B in rat brain homogenates indicated that at least 75% of MAO-B activity in rat brain had to be inhibited to induce the PEA syndrome. A good correlation was found between the abilities of MAO-B inhibitors to induce the behavioral syndrome and to increase levels of PEA in rat brain. Specific MAO-A inhibitors potentiated the behavioral effect of the MAO-B inhibitor deprenyl, while they did not induce the syndrome themselves or only at very high doses. Inhibitors of the reuptake of 5-HT or noradrenaline were inactive under the described experimental conditions. This behavioral test system seems to be useful in vivo screening test in rats for detecting compounds with strong MAO-B inhibiting activity. 相似文献